Orbis announces partnership with IDEMIA

27 January 2021

Orbis Diagnostics and IDEMIA, the global leader in Augmented Identity, have today announced a partnership to support the reopening of international borders.

The aim of the partnership between IDEMIA & Orbis is to develop and deploy a complete immunity testing platform solution for the air travel industry that enables the best passenger experience without compromising on security.

IDEMIA invented the eGate and is the leading global provider of end-to-endsolutions to facilitate travel across all ports (land, sea, air) including the critical step of securing border control.

We’re excited to be collaborating with a leading-edge company to solve a massive global challenge.